Advertisement
New Zealand markets open in 1 hour 21 minutes
  • NZX 50

    11,717.43
    -117.57 (-0.99%)
     
  • NZD/USD

    0.6088
    +0.0004 (+0.07%)
     
  • ALL ORDS

    8,013.80
    +11.00 (+0.14%)
     
  • OIL

    81.46
    -0.08 (-0.10%)
     
  • GOLD

    2,336.90
    -2.70 (-0.12%)
     

Is It Too Late To Consider Buying Aramark (NYSE:ARMK)?

Aramark (NYSE:ARMK), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$34.06 at one point, and dropping to the lows of US$30.75. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Aramark's current trading price of US$33.67 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Aramark’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for Aramark

What's The Opportunity In Aramark?

According to our valuation model, Aramark seems to be fairly priced at around 14% below our intrinsic value, which means if you buy Aramark today, you’d be paying a fair price for it. And if you believe that the stock is really worth $39.26, then there isn’t much room for the share price grow beyond what it’s currently trading. Although, there may be an opportunity to buy in the future. This is because Aramark’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of Aramark look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with a negative profit growth of -10% expected over the next couple of years, near-term growth certainly doesn’t appear to be a driver for a buy decision for Aramark. This certainty tips the risk-return scale towards higher risk.

What This Means For You

Are you a shareholder? Currently, ARMK appears to be trading around its fair value, but given the uncertainty from negative returns in the future, this could be the right time to reduce the risk in your portfolio. Is your current exposure to the stock beneficial for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on the stock, take a look at whether its fundamentals have changed.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on ARMK for a while, now may not be the most optimal time to buy, given it is trading around its fair value. The stock appears to be trading at fair value, which means there’s less benefit from mispricing. Furthermore, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven’t considered today, which can help gel your views on ARMK should the price fluctuate below its true value.

With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. For instance, we've identified 3 warning signs for Aramark (2 make us uncomfortable) you should be familiar with.

If you are no longer interested in Aramark, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com